Glucotrack (GCTK) Long-Term Deferred Tax (2017 - 2021)

Glucotrack's Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $11.7 million for Q4 2021.

• Quarterly Long-Term Deferred Tax rose 7.03% year-over-year to $11.7 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $11.7 million (up 7.03% YoY) and the FY2021 annual result came in at $11.7 million, up 7.03% from the prior year.
• Long-Term Deferred Tax was $11.7 million for Q4 2021 at Glucotrack, up from $10.9 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $11.7 million in Q4 2021 and bottomed at $8.9 million in Q4 2018.
• A 4-year average of $10.5 million and a median of $10.6 million in 2017 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2018 — Long-Term Deferred Tax retreated 13.8% — and 2021, when it grew 7.03%.
• Glucotrack's Long-Term Deferred Tax stood at $10.4 million in 2017, then slipped by 13.8% to $8.9 million in 2018, then grew by 22.0% to $10.9 million in 2020, then gained by 7.03% to $11.7 million in 2021.
• Business Quant data shows GCTK's Long-Term Deferred Tax at $11.7 million in Q4 2021, $10.9 million in Q4 2020, and $8.9 million in Q4 2018.